folfoxiri
Showing 1 - 21 of 21
Rectal Cancer Trial in Shanghai (FOLFOXIRI, CapeOX)
Recruiting
- Rectal Cancer
- FOLFOXIRI
- CapeOX
-
Shanghai, Shanghai, ChinaDepartment of Colorectal Surgery Fudan University Shanghai Caner
Feb 16, 2022
Rectal Cancer Trial in Stanford (FOLFOXIRI, FOLFOX regimen, XELOX)
Recruiting
- Rectal Cancer
- FOLFOXIRI
- +3 more
-
Stanford, CaliforniaStanford University
Jan 13, 2022
Colon Cancer Stage III Trial in Daejeon (FOLFOXIRI, mFOLFOX 6)
Recruiting
- Colon Cancer Stage III
- FOLFOXIRI
- mFOLFOX 6
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Dec 17, 2021
Liver Metastasis Colon Cancer Trial in Shanghai (Cetuximab, Bevacizumab, FOLFOXIRI)
Recruiting
- Liver Metastasis Colon Cancer
- Cetuximab
- +2 more
-
Shanghai, Shanghai, ChinaDepartment of Colorectal Surgery Fudan University Shanghai Cance
Apr 5, 2021
Colorectal Tumors, Drug Therapy Trial in Shenyang (FOLFOXIRI)
Recruiting
- Colorectal Neoplasms
- Drug Therapy
- FOLFOXIRI
-
Shenyang, Liaoning, ChinaLiaoning cancer hospital
Apr 13, 2021
Rectal Cancer Trial in Guangzhou (FOLFOXIRI)
Completed
- Rectal Cancer
- FOLFOXIRI
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yatsen University
Apr 10, 2021
Colonic Tumors, Drug Therapy Trial in Shenyang (FOLFOXIRI)
Recruiting
- Colonic Neoplasms
- Drug Therapy
- FOLFOXIRI
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital
Apr 14, 2021
Rectal Tumors, Drug Therapy, Radiation Trial in Shenyang (FOLFOXIRI, Short-Course Radiation Therapy(5Gy*5), XELOX)
Recruiting
- Rectal Neoplasms
- +2 more
- FOLFOXIRI
- +2 more
-
Shenyang, ChinaChina Medical University
Apr 13, 2021
Metastatic Colorectal Cancer Trial in Germany (FOLFOXIRI + Panitumumab, FOLFOXIRI)
Active, not recruiting
- Metastatic Colorectal Cancer
- FOLFOXIRI + Panitumumab
- FOLFOXIRI
-
Esslingen, Baden-Württemberg, Germany
- +18 more
Apr 24, 2021
Locally Advanced Rectal Cancer Trial in Beijing (FOLFOXIRI)
Completed
- Locally Advanced Rectal Cancer
- FOLFOXIRI
-
Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese ACademy of Medic
Jan 29, 2021
Metastatic Colorectal Cancer Trial in France (FOLFOXIRI, FOLFOX, FOLFIRI)
Recruiting
- Metastatic Colorectal Cancer
- FOLFOXIRI
- +5 more
-
Besançon, France
- +11 more
Jul 26, 2021
Metastatic Colorectal Cancer Trial in Guangzhou (FOLFOXIRI + Cetuximab, FOLFOXIRI)
Completed
- Metastatic Colorectal Cancer
- FOLFOXIRI + Cetuximab
- FOLFOXIRI
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Mar 28, 2020
Rectal Cancer Trial in Nanning (FOLFOXIRI)
Withdrawn
- Rectal Cancer
- FOLFOXIRI
-
Nanning, Guangxi Autonomous Region, ChinaAffiliated Tumor Hospital of Guangxi Medical University
Aug 6, 2019
Rectal Cancer Trial in Guangzhou (drug, other, procedure)
Recruiting
- Rectal Cancer
- FOLFOXIRI
- +4 more
-
Guangzhou, Guangdong, China
- +1 more
Jan 20, 2019
Metastatic Colon Cancer Patients Treated by FOLFOXIRI
Completed
- Colorectal Cancer
- FOLFOXIRI
-
Hanoi, VietnamHanoi Medical University
Apr 12, 2018
Rectal Cancer Trial in Shanghai (FOLFOXIRI)
Recruiting
- Rectal Cancer
- FOLFOXIRI
-
Shanghai, Shanghai, ChinaEthics Committee of Renji Hospital, School of Medicine,Shanghai
Jan 1, 2018
Metastatic Colorectal Cancer Trial in Guangzhou (FOLFOXIRI + Bevacizumab, FOLFOXIRI)
Unknown status
- Metastatic Colorectal Cancer
- FOLFOXIRI + Bevacizumab
- FOLFOXIRI
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Sep 19, 2016
Pancreatic Carcinoma Stage III Trial in Pisa (FOLFOXIRI)
Completed
- Pancreatic Carcinoma Stage III
- FOLFOXIRI
-
Pisa, PI, ItalyAzienda Ospedaliero-Universitaria Pisana
Jan 27, 2015
Pancreatic Cancer Trial in Pisa (FOLFOXIRI, Gemcitabine)
Unknown status
- Pancreatic Cancer
- FOLFOXIRI
- Gemcitabine
-
Pisa, PI, ItalyAzienda Ospedaliero-Universitaria Pisana
Feb 3, 2015
Metastatic Colorectal Cancer Trial in Guangzhou (FOLFOXIRI, FOLFOX)
Unknown status
- Metastatic Colorectal Cancer
- FOLFOXIRI
- FOLFOX
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
May 6, 2014